- Home
- MAIA vs SQNS Comparison
MAIA vs SQNS Comparison
Compare MAIA & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- SQNS
- Stock Information
- Founded
- MAIA 2018
- SQNS 2003
- Country
- MAIA United States
- SQNS France
- Employees
- MAIA N/A
- SQNS N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- SQNS Semiconductors
- Sector
- MAIA Health Care
- SQNS Technology
- Exchange
- MAIA Nasdaq
- SQNS Nasdaq
- Market Cap
- MAIA 46.7M
- SQNS 46.5M
- IPO Year
- MAIA 2022
- SQNS 2011
- Fundamental
- Price
- MAIA $1.74
- SQNS $1.33
- Analyst Decision
- MAIA
- SQNS Strong Buy
- Analyst Count
- MAIA 0
- SQNS 1
- Target Price
- MAIA N/A
- SQNS $7.50
- AVG Volume (30 Days)
- MAIA 417.6K
- SQNS 878.9K
- Earning Date
- MAIA 08-08-2025
- SQNS 08-22-2025
- Dividend Yield
- MAIA N/A
- SQNS N/A
- EPS Growth
- MAIA N/A
- SQNS N/A
- EPS
- MAIA N/A
- SQNS 2.16
- Revenue
- MAIA N/A
- SQNS $38,858,000.00
- Revenue This Year
- MAIA N/A
- SQNS N/A
- Revenue Next Year
- MAIA N/A
- SQNS $93.87
- P/E Ratio
- MAIA N/A
- SQNS $0.69
- Revenue Growth
- MAIA N/A
- SQNS 40.06
- 52 Week Low
- MAIA $1.40
- SQNS $0.95
- 52 Week High
- MAIA $4.24
- SQNS $4.28
- Technical
- Relative Strength Index (RSI)
- MAIA 47.75
- SQNS 27.07
- Support Level
- MAIA $1.66
- SQNS $1.49
- Resistance Level
- MAIA $1.95
- SQNS $2.33
- Average True Range (ATR)
- MAIA 0.12
- SQNS 0.20
- MACD
- MAIA -0.00
- SQNS -0.05
- Stochastic Oscillator
- MAIA 31.82
- SQNS 6.54
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.